Magdy L. Shenouda

Internal Medicine
1729 Belmar Boulevard
Wall, NJ 7719.

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: safety, tolerability, and effects on glucose, insulin, and glucagon levels.

An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: safety, tolerability, and effects on glucose, insulin, and glucagon levels.

Journal: American journal of therapeutics
Published: June 21, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026